Eilersen Electric Digital Systems A/S (Denmark) - How Repligen ensures stable bioprocessing with Eilersen digital capacitive load cells From fermentation to purification, Eilersen’s digital capacitive…
Eilersen Electric Digital Systems A/S (Denmark) - How Repligen ensures stable bioprocessing with Eilersen digital capacitive load cells From fermentation to purification, Eilersen’s digital capacitive…
On November 6, 2026, in connection with the consummation of previously announced private exchange and subscription transactions, Repligen Corporation issued $1.0 billion aggregate principal amount of its 0.25% Convertible Senior Notes due 2031 under an Indenture, dated November 6, 2026 , ...
On November 6, 2026, in connection with the consummation of previously announced private exchange and subscription transactions, Repligen Corporation issued $1.0 billion aggregate principal amount of its 0.25% Convertible Senior Notes due 2031 under an Indenture, dated November 6, 2026 , ...
https://www.stocktitan.net/news/RGEN/repligen-announces-1-billion-private-convertible-senior-notes-0m6udkschdsb.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/RGEN/repligen-announces-1-billion-private-convertible-senior-notes-0m6udkschdsb.html?utm_source=stocktitan-bluesky&utm_medium=social
On October 30, 2026, Repligen Corporation issued a press release announcing the entry into privately negotiated exchange and/or subscription agreements with certain holders of its outstanding 1.00% Convertible Senior Notes due 2028 and certain new investors, pursuant to which the Company ...
On October 30, 2026, Repligen Corporation issued a press release announcing the entry into privately negotiated exchange and/or subscription agreements with certain holders of its outstanding 1.00% Convertible Senior Notes due 2028 and certain new investors, pursuant to which the Company ...
Ticker: $RGEN
Company: Repligen Corporation
Sector: Healthcare
Industry: Medical Instruments & Supplies
# Employees: 2,000
Recent Close: $175.80
52-Week High: $198.87
52-Week High Date: 09-28-2026
% Off 52-Week High: -11.60%
52-Week Low: $100.99
Ticker: $RGEN
Company: Repligen Corporation
Sector: Healthcare
Industry: Medical Instruments & Supplies
# Employees: 2,000
Recent Close: $175.80
52-Week High: $198.87
52-Week High Date: 09-28-2026
% Off 52-Week High: -11.60%
52-Week Low: $100.99
https://www.stocktitan.net/news/RGEN/repligen-reports-third-quarter-2026-financial-results-and-updates-n0jkjgh25tnc.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/RGEN/repligen-reports-third-quarter-2026-financial-results-and-updates-n0jkjgh25tnc.html?utm_source=stocktitan-bluesky&utm_medium=social
📈 Watsco releases Q3 2026 financial results report
📑 Dorman Products published 2026 Q3 earnings deck
📑 PayPal Holdings published 2026 Q3 earnings deck
📈 Watsco releases Q3 2026 financial results report
📑 Dorman Products published 2026 Q3 earnings deck
📑 PayPal Holdings published 2026 Q3 earnings deck
🔹 Revenue: $209.00M
🔹 Adj. EPS: $0.53
🔹 GAAP EPS: $0.68
🔹 Gross Margin: 53.0%
FY 2026 Guide:
🔹 Total Reported Revenue: $844M - $852M
🔹 Reported Growth: 14.5% - 15.5%
🔹 Organic Growth: 12% - 13%
Other Q Metrics:
🔹 Operating Income
https://financier.news/
🔹 Revenue: $209.00M
🔹 Adj. EPS: $0.53
🔹 GAAP EPS: $0.68
🔹 Gross Margin: 53.0%
FY 2026 Guide:
🔹 Total Reported Revenue: $844M - $852M
🔹 Reported Growth: 14.5% - 15.5%
🔹 Organic Growth: 12% - 13%
Other Q Metrics:
🔹 Operating Income
https://financier.news/
https://fundspec.ai/s/RGEN/earnings
Know who reports today, with an AI probability of a beat or a miss.
https://fundspec.ai/s/RGEN/earnings
Know who reports today, with an AI probability of a beat or a miss.
On October 27, 2026, Repligen Corporation announced its financial results for the third quarter ended September 30, 2026. The full text of the press release issued in connection with the announcement is attached as Exhibit 99.1 to this Current Report on Form 8-K. The information in this F...
On October 27, 2026, Repligen Corporation announced its financial results for the third quarter ended September 30, 2026. The full text of the press release issued in connection with the announcement is attached as Exhibit 99.1 to this Current Report on Form 8-K. The information in this F...
FMR LLC: now 13% (about $1.3B)
SEC Schedule 13G/A · filed Oct 7
#Investing #Stocks
Follow @elixstocksdata for daily institutional & insider activity.
FMR LLC: now 13% (about $1.3B)
SEC Schedule 13G/A · filed Oct 7
#Investing #Stocks
Follow @elixstocksdata for daily institutional & insider activity.
MD&A now says: "Management's Discussion and Analysis of Financial Condition and Results of Operations 19"
📈 Full redline → https://www.formdelta.com/ticker/RGEN
#10Q #RGEN #StockMarket
MD&A now says: "Management's Discussion and Analysis of Financial Condition and Results of Operations 19"
📈 Full redline → https://www.formdelta.com/ticker/RGEN
#10Q #RGEN #StockMarket
Repligen Corporation (RGEN) completed its acquisition of BioLife Solutions, Inc. (BLFS), a cell processing tools and services provider for the cell and gene therapy market.
🧵 continued ↓
Repligen Corporation (RGEN) completed its acquisition of BioLife Solutions, Inc. (BLFS), a cell processing tools and services provider for the cell and gene therapy market.
🧵 continued ↓
🚀 Free alerts → https://gunpowderalerts.com/go?utm_source=bluesky&utm_medium=social&utm_campaign=high_priority_filing
#Investing #FinancialDisclosure #8K
🚀 Free alerts → https://gunpowderalerts.com/go?utm_source=bluesky&utm_medium=social&utm_campaign=high_priority_filing
#Investing #FinancialDisclosure #8K
50 filings · 24 HIGH · 26 MEDIUM
Today's digest reveals a market bifurcated between AI-driven growth stories (e.g., **Fortrea**, **Repligen**) and value-trap financials (e.g., **Chiba Bank**).
#Finance #Alpha #SECfilings
🧵 See Thread ↓
50 filings · 24 HIGH · 26 MEDIUM
Today's digest reveals a market bifurcated between AI-driven growth stories (e.g., **Fortrea**, **Repligen**) and value-trap financials (e.g., **Chiba Bank**).
#Finance #Alpha #SECfilings
🧵 See Thread ↓
Repligen raised its full-year organic growth outlook to a range of 10.5% to 13.5% following a second-quarter performance that outpaced prior expecta…
Read more: https://embers.news/article/repligen-raises-guidance-to-135-on-organic-growth-64445
Repligen raised its full-year organic growth outlook to a range of 10.5% to 13.5% following a second-quarter performance that outpaced prior expecta…
Read more: https://embers.news/article/repligen-raises-guidance-to-135-on-organic-growth-64445
On September 10, 2026, Karen A. Dawes notified Repligen Corporation that she will be retiring from the Repligen Board of Directors after over twenty years of distinguished service to Repligen, effective as of September 30, 2026. Ms. Dawes commented, “It has been a privilege and an honor t...
On September 10, 2026, Karen A. Dawes notified Repligen Corporation that she will be retiring from the Repligen Board of Directors after over twenty years of distinguished service to Repligen, effective as of September 30, 2026. Ms. Dawes commented, “It has been a privilege and an honor t...